A comparison of rate control and rhythm control in patients with atrial fibrillation

Cited by (1,006)

Items 401–500 of 1,006

1. Genetic mechanisms of atrial fibrillation: impact on response to treatment
   Dawood Darbar, Dan M. Roden · 2013 · Nature Reviews Cardiology
2. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation
   Arribas, F., Ormaetxe, J. M., Peinado, R., Perulero, N., Ramirez, P., Badia, X. · 2010 · Europace
3. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry
   for the ATRIUM investigators, Meinertz, Thomas, Kirch, Wilhelm, Rosin, Ludger, Pittrow, David, Willich, Stefan N., Kirchhof, Paulus · 2011 · Clinical Research in Cardiology
4. Rhythm Control in Heart Failure Patients With Atrial Fibrillation
   Kevin M. Trulock, Sanjiv M. Narayan, Jonathan Paul Piccini · 2014 · Journal of the American College of Cardiology
5. Atrial Fibrillation in the Elderly
   Margaret C. Fang, Jane Chen, Michael W. Rich · 2007 · The American Journal of Medicine
6. Patient factors associated with quality of life in atrial fibrillation
   Tiffany C. Randolph, DaJuanicia N. Simon, Laine Elliott Thomas, Larry A. Allen, Gregg C. Fonarow, Bernard John Gersh, Peter Russell Kowey, James A. Reiffel, Gerald V. Naccarelli, Paul S. Chan et al. · 2016 · American Heart Journal
7. Pharmacological Cardioversion of Atrial Fibrillation
   Giuseppe Boriani, Igor Diemberger, Mauro Biffi, Cristian Martignani, Angelo Branzi · 2004 · Drugs
8. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: No effect on ablation outcome after ablation of atrial fibrillation
   Bernhard Richter, Michael Derntl, Manfred Marx, Peter Lercher, Heinz Gössinger · 2006 · American Heart Journal
9. State of the Art: Catheter Ablation of Atrial Fibrillation
   Matthew James Wright, Michel Haı̈ssaguerre, Sébastien Knecht, Seiichiro Matsuo, Mark D O'Neill, Isabelle Nault, Nicolas Lellouche, Mélèze Hocini, Frédéric Sacher, Pierre Jaı̈s · 2008 · Journal of Cardiovascular Electrophysiology
10. Amiodarone: an effective antiarrhythmic drug with unusual side effects
    LIESELOT VAN ERVEN, Martin Jan Schalij · 2010 · Heart
11. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging
    Boris A. Lutomsky, Thomas Rostock, A Koops, Daniel Steven, Kai Müllerleile, Helge Servatius, Imke Drewitz, D. Ueberschar, Thorsten Plagemann, Rodolfo Ventura et al. · 2008 · EP Europace
12. More Reasons Why Men and Women Are Not the Same (Gender Differences in Electrophysiology and Arrhythmias)
    Michael J. Yarnoz, Anne B. Curtis · 2008 · The American Journal of Cardiology
13. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials
    Jonathan G. Howlett, Robert Samuel McKelvie, J. Malcolm O. Arnold, Jeannine Costigan, Paul Dorian, Anique Ducharme, Estrellita Estrella-Holder, Justin Adrian Ezekowitz, Nadia Giannetti, Haissam A. Haddad et al. · 2009 · Canadian Journal of Cardiology
14. Catheter Ablation for Atrial Fibrillation
    Oussama M. Wazni, Bruce Larry Wilkoff, Walid I. Saliba · 2011 · New England Journal of Medicine
15. Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials
    Steve Deitelzweig, Alpesh Amin, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham · 2012 · Journal of Medical Economics
16. Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation
    Rohan Sajeev Wijesurendra, Alexander Liu, Christian Eichhorn, Rina Ariga, Eylem Levelt, William T. Clarke, Christopher T. Rodgers, Theodoros D. Karamitsos, Yaver Bashir, Matthew Ginks et al. · 2016 · Circulation
17. Effects of a Highly Selective Acetylcholine-Activated K + Channel Blocker on Experimental Atrial Fibrillation
    Taiichi Machida, Norio Hashimoto, Ippei Kuwahara, Yasuhiro Ogino, Junji Matsuura, Wataru Yamamoto, Yasuhiro Itano, Akira Zamma, Ryo Matsumoto, Junji Kamon et al. · 2010 · Circulation Arrhythmia and Electrophysiology
18. Atrial Fibrillation: A Perspective
    D. George Wyse, Bernard John Gersh · 2004 · Circulation
19. Association Between Atrial Fibrillation and Sudden Cardiac Death
    Victor Waldmann, Xavier Jouven, Kumar Narayanan, Olivier Piot, Sumeet S. Chugh, Christine M. Albert, Éloi Marijon · 2020 · Circulation Research
20. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation
    Celaleddin Demircan · 2005 · Emergency Medicine Journal
21. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
    Matthias Hammwöhner, Annelore Ittenson, Jutta Dierkes, Alicja Bukowska, Helmut Klein, Uwe Lendeckel, Andreas Goette · 2007 · PubMed
22. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
    Carmelo Lafuente‐Lafuente, Miguel Angel Longás-Tejero, Jean‐François Bergmann, Joël Belmin · 2012 · Cochrane Database of Systematic Reviews
23. Management of Arrhythmias in Heart Failure
    Daniele Masarone, Giuseppe Limongelli, Marta Rubino, Fabio Valente, Rossella Vastarella, Ernesto Ammendola, Rita Gravino, Marina Verrengia, Gemma Salerno, Giuseppe Pacileo · 2017 · Journal of Cardiovascular Development and Disease
24. IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation
    Juan Luis Tamargo, Ricardo Caballero, Ricardo J. Gómez, Eva Delpón · 2009 · Expert Opinion on Investigational Drugs
25. Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial
    Lim, K.-T., Davis, M. J.E., Powell, A., Arnolda, L., Moulden, K., Bulsara, M., Weerasooriya, R. · 2007 · Europace
26. Atrial fibrillation in women: treatment
    Darae Ko, Faisal Rahman, Maria Auxiliadora Parreiras Martins, Elaine M. Hylek, Patrick T. Ellinor, Renate B. Schnabel, Emelia J. Benjamin, Ingrid Elisabeth Christophersen · 2016 · Nature Reviews Cardiology
27. Obesity: physiologic changes and implications for preoperative management
    Vilma E. Ortiz, Jean Kwo · 2015 · BMC Anesthesiology
28. Left Ventricular Dysfunction in Atrial Fibrillation: Restoration of Sinus Rhythm by the Cox-Maze Procedure Significantly Improves Systolic Function and Functional Status
    John M. Stulak, Joseph A. Dearani, Richard C. Daly, Kenton J. Zehr, Thoralf M. Sundt, Hartzell Vernon Schaff · 2006 · The Annals of Thoracic Surgery
29. A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation
    Riccardo Proietti, Alexios E. Hadjis, Ahmed AlTurki, George Thanassoulis, Jean-François Roux, Atul Verma, Jeff S. Healey, Martin Bernier, David H. Birnie, Stanley Nattel et al. · 2015 · JACC. Clinical electrophysiology
30. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome
    L Kristensen, J C Nielsen, P T Mortensen, O L Pedersen, A K Pedersen, H R Andersen · 2004 · Heart
31. A Multi-Institutional Experience With the CryoMaze Procedure
    James S. Gammie, John C. Laschinger, James M. Brown, Robert S. Poston, Richard N. Pierson, Linda G. Romar, Kimberly Schwartz, Mary J. Santos, Bartley P. Griffith · 2005 · The Annals of Thoracic Surgery
32. Atrial fibrillation: A major risk factor for cognitive decline
    Dawn S. Hui, John Edward Morley, Peter C. Mikolajczak, Richard Lee · 2015 · American Heart Journal
33. Atrial Fibrillation Ablation: State of the Art
    Carlo Pappone, Vincenzo Santinelli · 2005 · The American Journal of Cardiology
34. Surgical Ablation for Atrial Fibrillation in Cardiac Surgery a Meta-Analysis and Systematic Review
    Davy Cheng, Niv Ad, Janet E Martin, E Berglin, Byung‐Chul Chang, George Doukas, James S. Gammie, Takashi Nitta, Randall Kevin Wolf, John D. Puskas · 2010 · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery
35. Cost-Effectiveness of Outpatient Cardiac Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
    Hooman Kamel, Manu Hegde, Derek R. Johnson, Brian F. Gage, S. Claiborne Johnston · 2010 · Stroke
36. Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: The importance of rhythm and rate control
    Sotirios Nedios, Philipp Sommer, Nikolaos Dagres, Jędrzej Kosiuk, Arash Arya, Sergio Richter, Thomas Gaspar, Nikolaos Kanagkinis, Borislav Dinov, Christopher Piorkowski et al. · 2014 · Heart Rhythm
37. Rationale and Design of ATHENA: A Placebo‐Controlled, Double‐Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter
    Stefan Hans Hohnloser, Stuart J. Connolly, Harry J.G.M. Crijns, Richard L. Page, Werner Seiz, Christian Torp-Petersen · 2007 · Journal of Cardiovascular Electrophysiology
38. Digoxin and Risk of Death in Adults With Atrial Fibrillation
    James V. Freeman, Kristi Reynolds, Margaret C. Fang, Natalia V. Udaltsova, Anthony E. Steimle, Niela K. Pomernacki, Leila H. Borowsky, Teresa N. Harrison, Daniel E. Singer, Alan S. Go · 2014 · Circulation Arrhythmia and Electrophysiology
39. Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
    Stephan Willems, Christian G. Meyer, Joseph Paul de Bono, Axel Brandes, Lars Eckardt, Arif Elvan, Isabelle C. Van Gelder, Andreas Goette, Michele Massimo Gulizia, Laurent Haegeli et al. · 2019 · European Heart Journal
40. The History of Atrial Fibrillation: The Last 100 Years
    Eric N. Prystowsky · 2008 · Journal of Cardiovascular Electrophysiology
41. A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation
    Kevin Stephen Channer · 2004 · European Heart Journal
42. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy
    Bernhard Maisch, Sabine Pankuweit · 2012 · Herz
43. Frequency of Supraventricular Arrhythmias in Patients With Idiopathic Pulmonary Arterial Hypertension
    Li Wen, Ming‐Li Sun, Pei An, Xin Jiang, Kai Sun, Zheng Lu, Qianqian Liu, Lan Wang, Qin‐Hua Zhao, Jing He et al. · 2014 · The American Journal of Cardiology
44. Benefits and Risks of Long-term Amiodarone Therapy for Persistent Atrial Fibrillation: A Meta-analysis
    James F. Doyle, Kwok Ming Ho · 2009 · Mayo Clinic Proceedings
45. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II
    Isabelle C. Van Gelder, Dirk Jan van Veldhuisen, Harry J.G.M. Crijns, Ype S. Tuininga, Jan G.P. Tijssen, Marco Alings, Hans A. Bosker, Jan Hein Cornel, Otto Kamp B, Nic J.G.M. Veeger et al. · 2006 · American Heart Journal
46. Irregular Rhythm Adversely Influences Calcium Handling in Ventricular Myocardium
    Liang‐Han Ling, Ouda Khammy, MELISSA J. BYRNE, Fatemah Amirahmadi, A. Foster, Gefeng Li, Linda Zhang, Cristobal G. dos Remedios, Chen Chen, David M. Kaye · 2012 · Circulation Heart Failure
47. Inhibitory G Protein Overexpression Provides Physiologically Relevant Heart Rate Control in Persistent Atrial Fibrillation
    Alexander Bauer, Amy D. McDonald, Khurram Nasir, Leah Peller, Jeffrey J. Rade, Julie M. Miller, Alan W. Heldman, J. Kevin Donahue · 2004 · Circulation
48. Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial
    Carline J. van den Dries, Sander van Doorn, Frans Hendrik Rutten, Ruud Oudega, Sjef J. C. M. van de Leur, Arif Elvan, Lisa Oude Grave, Henk J. G. Bilo, Karel G.M. Moons, Arno Wilhelmus Hoes et al. · 2020 · European Heart Journal
49. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation
    Mark Rodgers, Claire McKenna, Stephen Palmer, Duncan Chambers, Steven Van Hout, Su Golder, Chris Pepper, DERICK M. TODD, Nerys F. Woolacott · 2008 · Health Technology Assessment
50. Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score
    Daniela Poli, Emilia Antonucci, Rossella Marcucci, Cinzia Fatini, Brunetto Alterini, Lucia Mannini, Michela Falciani, Rosanna Abbate, Gian Franco Gensini, Domenico Prisco · 2007 · Thrombosis Research
51. Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus
    Mark E. Anderson · 2006 · Cardiovascular Research
52. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion
    Oussama M. Wazni, David O. Martin, Nassir F. Marrouche, Mustaphassim Shaaraoui, Mina K. Chung, Soufian Almahameed, Robert A. Schweikert, Walid Saliba, Andrea Natale · 2005 · Heart
53. Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
    Mark A. Crandall, David J. Bradley, Douglas L. Packer, Samuel J. Asirvatham · 2009 · Mayo Clinic Proceedings
54. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation
    Robert L. McNamara, Lawrence M. Brass, Joseph P. Drozda, Alan S. Go, Jonathan L. Halperin, Charles R. Kerr, Samuel Lévy, David J. Malenka, Suneet Mittal, Frank Pelosi et al. · 2004 · Journal of the American College of Cardiology
55. Relation of Obesity to Recurrence Rate and Burden of Atrial Fibrillation
    Maya E. Guglin, Kuldeep Maradia, Ren Chen, Anne B. Curtis · 2011 · The American Journal of Cardiology
56. Prevalence, Functional Impact, and Mortality of Atrial Fibrillation in an Older Italian Population (from the Pro.V.A. Study)
    Claudio Bilato, Maria‐Chiara Corti, Giovannella Baggio, Debora Rampazzo, Ada Cutolo, Sabino Iliceto, Gaetano Crepaldi · 2009 · The American Journal of Cardiology
57. Comparison of Rate Versus Rhythm Control for Atrial Fibrillation in Patients With Left Ventricular Dysfunction (from the AFFIRM Study)
    Ronald S. Freudenberger, Alan C. Wilson, John B. Kostis · 2007 · The American Journal of Cardiology
58. Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery
    Chen, Mien-Cheng, Chang, Jen-Ping, Chang, Hsueh-Wen · 2004 · Chest
59. Atrial Fibrillation–Mediated Cardiomyopathy
    Dingxin Qin, MOUSSA C. MANSOUR, Jeremy Neil Ruskin, Edwin Kevin Heist · 2019 · Circulation Arrhythmia and Electrophysiology
60. The impact of rapid atrial pacing on ADMA and endothelial NOS
    Andreas Goette, Matthias Hammwöhner, Alicja Bukowska, Fortunato Scalera, Jens Martens‐Lobenhoffer, Dobromir Dobrev, Ursula Ravens, Sönke Weinert, Senad Medunjanin, Uwe Lendeckel et al. · 2010 · International Journal of Cardiology
61. Prevalence and Prognostic Significance of Atrial Fibrillation in Outpatients With Heart Failure Due to Left Ventricular Systolic Dysfunction
    Pernille Corell, Finn Gustafsson, Morten Schou, John Markenvard, Tonny Nielsen, Per Rossen Hildebrandt · 2006 · European Journal of Heart Failure
62. An International View of How Recent‐onset Atrial Fibrillation Is Treated in the Emergency Department
    Carly Rogenstein, Anne‐Maree Kelly, Suzanne M Mason, Sandra M. Schneider, Eddy Lang, Catherine M. Clement, Ian Gilmour Stiell · 2012 · Academic Emergency Medicine
63. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter
    JoEllyn M. Abraham, Walid I. Saliba, Carolyn Vekstein, David Lawrence, Mandeep Bhargava, Mohamed Bassiouny, David Janiszewski, Bruce D. Lindsay, Michael Anthony Militello, Steven E. Nissen et al. · 2015 · Circulation Arrhythmia and Electrophysiology
64. Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels
    Adedotun Ogunsua, Amir Y. Shaikh, Mohamed Ahmed, David D. McManus · 2015 · Methodist DeBakey Cardiovascular Journal
65. Cardiovascular Disease in the Elderly
    Janice B. Schwartz, Douglas Peter Zipes · 2012 · Elsevier eBooks
66. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers
    Antonio Hernández‐Madrid, Irene Marín, Carlos Escobar Cervantes, Enrique Bernal, Jaime Escudero Estévez, Gerardo Moreno, Jorge Rondón, Jian Peng, Lilianna Limón, Sebastián Nannini et al. · 2004 · Journal of the Renin-Angiotensin-Aldosterone System
67. Comparison of Beta Blocker and Digoxin Alone and in Combination for Management of Patients With Atrial Fibrillation and Heart Failure
    Laurent Fauchier, Caroline Grimard, Bertrand Pierre, Emilie Nonin, Laurent Gorin, Bruno Rauzy, Pierre Cosnay, Dominique Babuty, B Charbonnier · 2008 · The American Journal of Cardiology
68. Effects of Atrial Fibrillation on Long-Term Outcomes in Patients Hospitalized for Heart Failure in Japan A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)
    Sanae Hamaguchi, Hisashi Yokoshiki, Shintaro Kinugawa, Miyuki Tsuchihashi‐Makaya, Takashi Yokota, Akira Takeshita, Hiroyuki Tsutsui, The JCARE-CARD Investigators · 2009 · Circulation Journal
69. Emergency Department Use of Intravenous Procainamide for Patients with Acute Atrial Fibrillation or Flutter
    Ian Gilmour Stiell, Catherine M. Clement, Cheryl Symington, Jeffrey Joseph Perry, Christian Vaillancourt, George A. Wells · 2007 · Academic Emergency Medicine
70. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model
    Gabriel Laurent, Gordon Willy Pak Ling Moe, Xudong Hu, BJ Holub, Howard M. Leong-Poi, Judy E. Trogadis, Kim Alexander Connelly, David W. Courtman, Bradley H. Strauss, Paul Dorian · 2007 · Cardiovascular Research
71. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management
    Lohit Garg, Manasvi Gupta, Syed Rafay Ali Sabzwari, Sahil Agrawal, Manyoo A. Agarwal, Talha F Nazir, Jeffrey P. Gordon, Babak Bozorgnia, Matthew W. Martinez · 2018 · Heart Failure Reviews
72. Obstructive Sleep Apnea and Atrial Fibrillation
    Amalia Ioanna Moula, Iris Parrini, Cecilia Tetta, Fabiana Lucà, Gianmarco Parise, Carmelo Massimiliano Rao, Emanuela Mauro, Orlando Parise, Francesco Matteucci, Michele Massimo Gulizia et al. · 2022 · Journal of Clinical Medicine
73. Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment
    Edwin Kevin Heist, Jeremy Neil Ruskin · 2006 · Progress in Cardiovascular Diseases
74. Cost Comparison of Catheter Ablation and Medical Therapy in Atrial Fibrillation
    Yaariv Khaykin, Carlos Arturo Morillo, Allan Cameron Skanes, Aaron McCracken, Karin H. Humphries, Charles R. Kerr · 2007 · Journal of Cardiovascular Electrophysiology
75. Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
    Oliver Adam, Hans‐Ruprecht Neuberger, Michael Böhm, Ulrich Laufs · 2008 · Circulation
76. Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
    Olivier Hanon, Patrick Assayag, Joël Belmin, Jean‐Philippe Collet, J.P. Émeriau, Laurent Fauchier, Françoise Forette, Patrick Friocourt, Armelle Gentric, Christophe Leclercq et al. · 2013 · Archives of cardiovascular diseases
77. Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis of Biventricular vs. Right Ventricular Pacing Mode
    Neal A. Chatterjee, Gaurav A. Upadhyay, Kenneth A. Ellenbogen, David L. Hayes, Jagmeet P. Singh · 2012 · European Journal of Heart Failure
78. Novel Approaches for Pharmacological Management of Atrial Fibrillation
    Joachim R. Ehrlich, Stanley Nattel · 2009 · Drugs
79. Atrial Fibrillation Significantly Increases Total Mortality and Stroke Risk Beyond that Conveyed by the CHADS2 Risk Factors
    Mark A. Crandall, Benjamin Davies Horne, JOHN D. DAY, Jeffrey L. Anderson, Joseph Brent Muhlestein, Brian G. Crandall, J. Peter Weiss, JEFFREY S. OSBORNE, DONALD L. LAPPE, Thomas Jared Bunch · 2009 · Pacing and Clinical Electrophysiology
80. Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
    Ilya M. Danelich, Jennifer M. Lose, Sampaguita S. Wright, Samuel J. Asirvatham, Beth A. Ballinger, David W. Larson, Jenna K. Lovely · 2014 · Journal of the American College of Surgeons
81. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM
    Katherine T. Murray, Jeffrey N. Rottman, Patrick G. Arbogast, Lynn R. Shemanski, R.Kirby Primm, W. Barton Campbell, Allen Jay Solomon, Jeffrey E. Olgin, M. Wilson, John Dimarco et al. · 2004 · Heart Rhythm
82. Predictive Capability of Left Atrial Size Measured by CT, TEE, and TTE for Recurrence of Atrial Fibrillation Following Radiofrequency Catheter Ablation
    Sachin S Parikh, Christian Jøns, Scott A McNitt, James P. Daubert, Karl Quentin Schwarz, BURR W. HALL · 2010 · Pacing and Clinical Electrophysiology
83. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing
    Qingyan Zhao, Shengbo Yu, Minghui Zou, Zixuan Dai, Xule Wang, Jinping Xiao, Congxin Huang · 2012 · Journal of Interventional Cardiac Electrophysiology
84. Características de los pacientes y abordaje terapéutico de la fibrilación auricular en atención primaria en España: Estudio FIATE
    José María Lobos-Bejarano, José Carlos del Castillo Rodríguez, Amparo Mena González, José Juan Alemán-Sánchez, Antonio Cabrera de León, Gonzalo Barón‐Esquivias, Agustín Pastor Fuentes · 2013 · Medicina Clínica
85. Randomized Trials Versus Common Sense and Clinical Observation
    Alexander C. Fanaroff, Robert M. Califf, Robert A. Harrington, Christopher Bull Granger, John J.V. McMurray, Manesh R. Patel, Deepak L. Bhatt, Stephan Windecker, Adrian F. Hernandez, Charles Michael Gibson et al. · 2020 · Journal of the American College of Cardiology
86. Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi
    Waldemar E. Wysokiński, Whyte G. Owen, David N. Fass, Dariusz Patrzałek, L. Murphy, Robert D. McBane · 2004 · Journal of Thrombosis and Haemostasis
87. Asymptomatic persistent atrial fibrillation and outcome: Results of the RACE study
    Michiel Rienstra, Rob A. Vermond, Harry J.G.M. Crijns, Jan G.P. Tijssen, Isabelle C. Van Gelder · 2014 · Heart Rhythm
88. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations
    Jeff S. Healey, Ratika Parkash, Tim Pollak, Teresa S.M. Tsang, Paul Dorian · 2011 · Canadian Journal of Cardiology
89. The role of echocardiography in atrial fibrillation and cardioversion
    Richard William Troughton, Craig R Asher, Allan L Klein · 2003 · Heart
90. Atrial fibrillation: Mechanistic insights and treatment options
    Sunil Mathew, Jigar Patel, Satheesh Joseph · 2009 · European Journal of Internal Medicine
91. Pulmonary Vein Isolation for the Treatment of Drug-Refractory Atrial Fibrillation in Adults with Congenital Heart Disease
    Femi Philip, Kamran I. Muhammad, Shikar Agarwal, Andrea Natale, Richard A. Krasuski · 2012 · Congenital Heart Disease
92. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation
    Fredrik Holmqvist · 2006 · European Heart Journal
93. Trends in Anticoagulation for Atrial Fibrillation in the U.S.
    Shane B. Rowan, Desiree N. Bailey, Caroline E. Bublitz, Robert J. Anderson · 2007 · Journal of the American College of Cardiology
94. Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians
    Edward C. Li, John S. Esterly, Shaunte Pohl, Shane D. Scott, Brian F. McBride · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
95. The left atrial function index: A rhythm independent marker of atrial function
    Liza Thomas, Michelle Hoy, Karen Byth, N B Schiller · 2007 · European Journal of Echocardiography
96. Use of Flecainide for the Treatment of Atrial Fibrillation
    Debra S. Echt, Jeremy Neil Ruskin · 2020 · The American Journal of Cardiology
97. Arrhythmias in the intensive care patient
    Hans‐Joachim Trappe, Bodo Brandts, PETER WEISMÜLLER · 2003 · Current Opinion in Critical Care
98. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation
    Tom J. R. De Potter, Antonio Berruezo, Lluı́s Mont, María Matiello, David Tamborero, C. Santibáñez, Begoña Benito, Nibaldo Zamorano, Josép Brugada · 2009 · EP Europace
99. Relation of C-Reactive Protein to Long-Term Risk of Recurrence of Atrial Fibrillation After Electrical Cardioversion
    Maria Luisa Loricchio, Cinzia Cianfrocca, Vincenzo Pasceri, Leopoldo Bianconi, Antonio Auriti, Leonardo Calò, Filippo Lamberti, Antonio Castro, Claudio Pandozi, A Palamara et al. · 2007 · The American Journal of Cardiology
100. The hERG potassium channel as a therapeutic target
     Harry J. Witchel · 2007 · Expert Opinion on Therapeutic Targets